University of California San Francisco

Leard
Lorriana Leard, MD

Associate Professor of Clinical Medicine
Division of Pulmonary & Critical Care Medicine
Department of Medicine
Associate Director, Pulmonary and Critical Care Medicine Fellowship

Address

505 Parnassus Avenue, #M1336A
San Francisco, CA 94117
United States

Phone: 415-353-4145

ORCID: 0000-0003-3417-2524

Biography

Dr. Lorri Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco and joined the faculty in 2006. She pursued further training in medical education in the UCSF Teaching Scholars program and was selected to join the Academy of Medical Educators in 2011.

Dr. Leard is Associate Dean for Continuing Medical Education for the UCSF School of Medicine and Vice Chief of Clinical Operations for the UCSF Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Her major academic interests include Medical Education, Lung Transplantation and Lung Cancer. She cares for patients on the Advanced Lung Disease Service at UCSF Moffitt-Long Hospital, and sees patients at the Mt. Zion Comprehensive Cancer Center.

She is a past president of the California Thoracic Society. She serves on Item Review Committees for the National Board of Medical Educators and is an Editorial Board Consultant for the Journal of Heart and Lung Transplantation. She is Vice Chair (2023-2024) of the Committee on Academic Personnel -Gold Committee.

Videos

Awards & Honors

Award Conferred By Date
V. Courtney Broaddus Award for Leadership and Service UCSF 2022
Academy of Medical Educators UCSF 2011
Michael S. Stulbarg Outstanding Teaching Award UCSF 2007

Education

Institution Degree Dept or School End Date
University of California Relationship-Centered Communication Skills for Racial Equity in Healthcare 2019
University of California Diversity, Equity, and Inclusion Champion Training 2018
University of California Fellowship Lung Transplantation 2006
University of California Fellowship Pulmonary and Critical Care Medicine 2005
University of Texas Southwestern Internship & Residency Internal Medicine 2001
University of California M.D. School of Medicine 1998

Board Certifications

American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine -  Critical Care Medicine
American Board of Internal Medicine - Pulmonary Disease

Clinical Expertise

Malignant Mesothelioma
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lung Cancer Screening
Pulmonary (lung) Metastases
Tracheal/Bronchial Stent Placement
Transbronchial Needle Aspiration (TBNA)
Endobronchial Ultrasound (EBUS)
Tracheobronchial Dilatation

Program Affiliations

Thoracic Oncology Progam

Lung Transplant Program

Lung Cancer Screening Program

Research Narrative

Dr. Leard's current research interests include (1) Assessment of the role of Donor Specific Antibodies in the development of Bronchiolitis obliterans, (2) Bronchoscopy Complications, and (3) Lung Cancer Screening.

Research Interests

Lung Cancer Screening & Surveillance
Complications of Lung Transplantation

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 67
  1. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
    Calabrese DR, Ekstrand CA, Yellamilli S, Singer JP, Hays SR, Leard LE, Shah RJ, Venado A, Kolaitis NA, Perez A, Combes A, Greenland JR| | View in PubMed
  2. CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury.
    Santos J, Wang P, Shemesh A, Liu F, Tsao T, Aguilar OA, Cleary SJ, Singer JP, Gao Y, Hays SR, Golden JA, Leard L, Kleinhenz ME, Kolaitis NA, Shah R, Venado A, Kukreja J, Weigt SS, Belperio JA, Lanier LL, Looney MR, Greenland JR, Calabrese DR| | View in PubMed
  3. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis.
    Santos J, Hays SR, Golden JA, Calabrese DR, Kolaitis N, Kleinhenz ME, Shah R, Estrada AV, Leard LE, Kukreja J, Singer JP, Greenland JR| | View in PubMed
  4. Development of the Lung Transplant Frailty Scale (LT-FS).
    Singer JP, Christie JD, Diamond JM, Anderson MA, Benvenuto LA, Gao Y, Arcasoy SM, Lederer DJ, Calabrese D, Wang P, Hays SR, Kukreja J, Venado A, Kolaitis NA, Leard LE, Shah RJ, Kleinhenz ME, Golden J, Betancourt L, Oyster M, Zaleski D, Adler J, Kalman L, Balar P, Patel S, Medikonda N, Koons B, Tevald M, Covinsky KE, Greenland JR, Katz PK| | View in PubMed
  5. Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function.
    Odisho AY, Liu AW, Maiorano AR, Bigazzi MOA, Medina E, Leard LE, Shah R, Venado A, Perez A, Golden J, Kleinhenz ME, Kolaitis NA, Maheshwari J, Trinh BN, Kukreja J, Greenland J, Calabrese D, Neinstein AB, Singer JP, Hays SR| | View in PubMed
  6. The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
    Kolaitis NA, Chen H, Calabrese DR, Kumar K, Obata J, Bach C, Golden JA, Simon MA, Kukreja J, Hays SR, Leard LE, Singer JP, De Marco T| | View in PubMed
  7. CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction.
    Calabrese DR, Chong T, Singer JP, Rajalingam R, Hays SR, Kukreja J, Leard L, Golden JA, Lanier LL, Greenland JR| | View in PubMed
  8. NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes.
    Calabrese DR, Tsao T, Magnen M, Valet C, Gao Y, Mallavia B, Tian JJ, Aminian EA, Wang KM, Shemesh A, Punzalan EB, Sarma A, Calfee CS, Christenson SA, Langelier CR, Hays SR, Golden JA, Leard LE, Kleinhenz ME, Kolaitis NA, Shah R, Venado A, Lanier LL, Greenland JR, Sayah DM, Ardehali A, Kukreja J, Weigt SS, Belperio JA, Singer JP, Looney MR| | View in PubMed
  9. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.
    Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M| | View in PubMed
  10. Response to selection of lung transplant candidates: A pediatric perspective on the ISHLT consensus document.
    Solomon M, Willemse BWM, Ramos KJ, Leard LE| | View in PubMed
  11. Depressive symptoms in lung transplant recipients: trajectory and association with mortality and allograft dysfunction.
    Kolaitis NA, Gao Y, Soong A, Greenland JR, Hays SR, Golden JA, Venado A, Leard LE, Shah RJ, Kleinhenz ME, Katz PP, Kukreja J, Blanc PD, Smith PJ, Singer JP| | View in PubMed
  12. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
    Greenland NY, Deiter F, Calabrese DR, Hays SR, Kukreja J, Leard LE, Kolaitis NA, Golden JA, Singer JP, Greenland JR| | View in PubMed
  13. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
    Warrior K, Leard LE, Nair AR, Gries CJ, Fisher AJ, Johnson SR, McCormack FX, Dilling DF| | View in PubMed
  14. What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis.
    Perez AA, Leard LE| | View in PubMed
  15. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.
    Dugger DT, Calabrese DR, Gao Y, Deiter F, Tsao T, Maheshwari J, Hays SR, Leard L, Kleinhenz ME, Shah R, Golden J, Kukreja J, Gordon ED, Singer JP, Greenland JR| | View in PubMed
  16. Construct and Predictive Validity of Sarcopenia in Lung Transplant Candidates.
    Maheshwari JA, Kolaitis NA, Anderson MR, Benvenuto L, Gao Y, Katz PP, Greenland J, Wolters PJ, Covinsky K, Hays SR, Kukreja J, Calabrese DR, Venado A, Shah RJ, Leard LE, Trinh B, Huang CY, Glidden D, Kleinhenz ME, Golden JA, Sutter N, Tietje-Ulrich G, Criner RN, Arcasoy SM, Christie JD, Diamond J, Singer JP| | View in PubMed
  17. Perceptions Around Lung Transplant-Associated Hypogammaglobulinemia.
    Lew J, Casey M, Leard LE, Hays S, Otani IM| | View in PubMed
  18. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.
    Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, Campos SV, Christon LM, Cypel M, Dellgren G, Hartwig MG, Kapnadak SG, Kolaitis NA, Kotloff RM, Patterson CM, Shlobin OA, Smith PJ, Solé A, Solomon M, Weill D, Wijsenbeek MS, Willemse BWM, Arcasoy SM, Ramos KJ| | View in PubMed
  19. The association of post-operative delirium with patient-reported outcomes and mortality after lung transplantation.
    DeBolt CL, Gao Y, Sutter N, Soong A, Leard L, Jeffrey G, Kleinhenz ME, Calabrese D, Greenland J, Venado A, Hays SR, Shah R, Kukreja J, Trinh B, Kolaitis NA, Douglas V, Diamond JM, Smith P, Singer J| | View in PubMed
  20. Lung transplantation from swimming pool drowning victims: A case series.
    Tsou S, Chen J, Brzezinski M, Hays S, Leard L, Singer JP, Trinh B, Kukreja J| | View in PubMed
  21. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
    Iasella CJ, Hoji A, Popescu I, Wei J, Snyder ME, Zhang Y, Xu W, Iouchmanov V, Koshy R, Brown M, Fung M, Langelier C, Lendermon EA, Dugger D, Shah R, Lee J, Johnson B, Golden J, Leard LE, Ellen Kleinhenz M, Kilaru S, Hays SR, Singer JP, Sanchez PG, Morrell MR, Pilewski JM, Greenland JR, Chen K, McDyer JF| | View in PubMed
  22. Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature.
    Dugger DT, Fung M, Hays SR, Singer JP, Kleinhenz ME, Leard LE, Golden JA, Shah RJ, Lee JS, Deiter F, Greenland NY, Jones KD, Langelier CR, Greenland JR| | View in PubMed
  23. Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression.
    Kolaitis NA, Gao Y, Soong A, Greenland JR, Hays SR, Golden J, Leard LE, Shah RJ, Kleinhenz ME, Katz PP, Venado A, Kukreja J, Blanc PD, Singer JP| | View in PubMed
  24. Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection.
    Dugger DT, Fung M, Zlock L, Caldera S, Sharp L, Hays SR, Singer JP, Leard LE, Golden JA, Shah RJ, Kukreja J, Gordon E, Finkbeiner W, Kleinhenz ME, Langelier C, Greenland JR| | View in PubMed
  25. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.
    Venado A, Kolaitis NA, Huang CY, Gao Y, Glidden DV, Soong A, Sutter N, Katz PP, Greenland JR, Calabrese DR, Hays SR, Golden JA, Shah RJ, Leard LE, Kukreja J, Deuse T, Wolters PJ, Covinsky K, Blanc PD, Singer JP| | View in PubMed
  26. Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis.
    Perez AA, Hays SR, Soong A, Gao Y, Greenland JR, Leard LE, Shah RJ, Golden J, Kukreja J, Venado A, Kleinhenz ME, Singer JP| | View in PubMed
  27. Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction.
    Mallavia B, Liu F, Lefrançais E, Cleary SJ, Kwaan N, Tian JJ, Magnen M, Sayah DM, Soong A, Chen J, Saggar R, Shino MY, Ross DJ, Derhovanessian A, Lynch JP, Ardehali A, Weigt SS, Belperio JA, Hays SR, Golden JA, Leard LE, Shah RJ, Kleinhenz ME, Venado A, Kukreja J, Singer JP, Looney MR| | View in PubMed
  28. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients.
    Kolaitis NA, Calabrese DR, Ahearn P, Venado A, Florez R, Lei HL, Isaak K, Henricksen E, Martinez E, Chong T, Shah RJ, Leard LE, Kleinhenz ME, Golden J, De Marco T, Greenland JR, Kukreja J, Hays SR, Blanc PD, Singer JP| | View in PubMed
  29. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: A single center experience.
    Perez AA, Singer JP, Schwartz BS, Chin-Hong P, Shah RJ, Kleinhenz ME, Gao Y, Venado A, Leard LE, Golden JA, Kukreja J, Greenland JR, Hays SR| | View in PubMed
  30. Gene signatures common to allograft rejection are associated with lymphocytic bronchitis.
    Greenland JR, Wang P, Brotman JJ, Ahuja R, Chong TA, Kleinhenz ME, Leard LE, Golden JA, Hays SR, Kukreja J, Singer JP, Rajalingam R, Jones K, Laszik ZG, Trivedi NN, Greenland NY, Blanc PD| | View in PubMed
  31. Frailty trajectories in adult lung transplantation: A cohort study.
    Venado A, McCulloch C, Greenland JR, Katz P, Soong A, Shrestha P, Hays S, Golden J, Shah R, Leard LE, Kleinhenz ME, Kukreja J, Zablotska L, Allen IE, Covinsky K, Blanc P, Singer JP| | View in PubMed
  32. Wildfires Disaster Guidance: Tips for Staying Healthy during Wildfires.
    Jamil S, Carlos WG, Leard L, Wang A, Santhosh L, Balmes J, Seam N, Dela Cruz CS| | View in PubMed
  33. Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
    Kolaitis NA, Kukreja J, Jones KD, Hays SR, Leard LE| | View in PubMed
  34. Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
    Hachem RR, Kamoun M, Budev MM, Askar M, Ahya VN, Lee JC, Levine DJ, Pollack MS, Dhillon GS, Weill D, Schechtman KB, Leard LE, Golden JA, Baxter-Lowe L, Mohanakumar T, Tyan DB, Yusen RD| | View in PubMed
  35. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
    Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Makani SS, Massion PP, Mazzone P, Merritt RE, Meyers BF, Midthun DE, Pipavath S, Pratt C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Schiebler ML, Tong BC, Travis WD, Wei B, Yang SC, Gregory KM, Hughes M| | View in PubMed
  36. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation.
    Kolaitis NA, Soong A, Shrestha P, Zhuo H, Neuhaus J, Katz PP, Greenland JR, Golden J, Leard LE, Shah RJ, Hays SR, Kukreja J, Kleinhenz ME, Blanc PD, Singer JP| | View in PubMed
  37. ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: Definitions, grading system, and therapeutics.
    Crespo MM, McCarthy DP, Hopkins PM, Clark SC, Budev M, Bermudez CA, Benden C, Eghtesady P, Lease ED, Leard L, D'Cunha J, Wigfield CH, Cypel M, Diamond JM, Yun JJ, Yarmus L, Machuzak M, Klepetko W, Verleden G, Hoetzenecker K, Dellgren G, Mulligan M| | View in PubMed
  38. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness.
    Baldwin MR, Singer JP, Huang D, Sell J, Gonzalez WC, Pollack LR, Maurer MS, D'Ovidio FF, Bacchetta M, Sonett JR, Arcasoy SM, Shah L, Robbins H, Hays SR, Kukreja J, Greenland JR, Shah RJ, Leard L, Morrell M, Gries C, Katz PP, Christie JD, Diamond JM, Lederer DJ| | View in PubMed
  39. Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts.
    Greenland JR, Wong CM, Ahuja R, Wang AS, Uchida C, Golden JA, Hays SR, Leard LE, Rajalingam R, Singer JP, Kukreja J, Wolters PJ, Caughey GH, Tang Q| | View in PubMed
  40. Lung transplantation after prior cardiothoracic surgery: To transplant or not to transplant.
    Leard LE| | View in PubMed
  41. Acquired acanthosis nigricans with tripe palms in a patient with interstitial lung disease.
    Danesh MJ, Saylor DK, Leard LE, North JP, Fox LP| | View in PubMed
  42. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.
    Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, Dean MY, Hersh B, Wolters PJ, Tokman S, Arcasoy SM, Ramphal K, Greenland JR, Smith N, Heffernan P, Shah L, Shrestha P, Golden JA, Blumenthal NP, Huang D, Sonett J, Hays S, Oyster M, Katz PP, Robbins H, Brown M, Leard LE, Kukreja J, Bacchetta M, Bush E, D'Ovidio F, Rushefski M, Raza K, Christie JD, Lederer DJ| | View in PubMed
  43. Prolonged Barium-Impaction Ileus in Two Lung Transplant Recipients With Systemic Sclerosis: Case Report.
    Tokman S, Hays SR, Leard LE, Bush EL, Kukreja J, Kleinhenz ME, Golden JA, Singer JP| | View in PubMed
  44. Lung transplantation for hypersensitivity pneumonitis.
    Kern RM, Singer JP, Koth L, Mooney J, Golden J, Hays S, Greenland J, Wolters P, Ghio E, Jones KD, Leard L, Kukreja J, Blanc PD| | View in PubMed
  45. Clinical outcomes of lung transplant recipients with telomerase mutations.
    Tokman S, Singer JP, Devine MS, Westall GP, Aubert JD, Tamm M, Snell GI, Lee JS, Goldberg HJ, Kukreja J, Golden JA, Leard LE, Garcia CK, Hays SR| | View in PubMed
  46. Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.
    Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M, National comprehension cancer network| | View in PubMed
  47. The feasibility of lung transplantation in HIV-seropositive patients.
    Kern RM, Seethamraju H, Blanc PD, Sinha N, Loebe M, Golden J, Kukreja J, Scheinin S, Hays S, Kleinhenz ME, Leard L, Hoopes C, Singer JP| | View in PubMed
  48. Development and validation of a lung transplant-specific disability questionnaire.
    Singer JP, Blanc PD, Dean YM, Hays S, Leard L, Kukreja J, Golden J, Katz PP| | View in PubMed
  49. A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions.
    Singer JP, Chen J, Blanc PD, Leard LE, Kukreja J, Chen H| | View in PubMed
  50. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
    Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE| | View in PubMed
  51. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection.
    Sayah DM, Koff JL, Leard LE, Hays SR, Golden JA, Singer JP| | View in PubMed
  52. Rapidly progressive pulmonary venoocclusive disease in young women taking oral contraceptives.
    Urisman A, Leard LE, Nathan M, Elicker BM, Hoopes C, Kukreja J, Jones KD| | View in PubMed
  53. Lung cancer screening.
    Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP, Leard L, Leung AN, Massion PP, Meyers BF, Munden RF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Schabath MB, Sequist LV, Tong BC, Travis WD, Unger M, Yang SC| | View in PubMed
  54. Use of sublingual tacrolimus in lung transplant recipients.
    Watkins KD, Boettger RF, Hanger KM, Leard LE, Golden JA, Hoopes CW, Singer JP| | View in PubMed
  55. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients.
    Smith L, Singer JP, Hayes M, Golden JA, Leard LE| | View in PubMed
  56. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation.
    Singer JP, Blanc PD, Hoopes C, Golden JA, Koff JL, Leard LE, Cheng S, Chen H| | View in PubMed
  57. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents.
    Tan JH, Fidelman N, Durack JC, Hays SR, Leard LL, Laberge JM, Kerlan RK, Golden JA, Gordon RL| | View in PubMed
  58. Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients.
    Singer JP, Huang MY, Hui C, Blanc PD, Boettger RF, Golden J, Watkins K, Hoopes C, Leard LE| | View in PubMed
  59. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis.
    Elicker BM, Golden JA, Ordovas KG, Leard L, Golden TR, Hays SR| | View in PubMed
  60. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility.
    Gasper WJ, Sweet MP, Golden JA, Hoopes C, Leard LE, Kleinhenz ME, Hays SR, Patti MG| | View in PubMed
  61. Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.
    Leard LE, Cho BK, Jones KD, Hays SR, Tope WD, Golden JA, Hoopes CW| | View in PubMed
  62. Antireflux surgery for patients with end-stage lung disease before and after lung transplantation.
    Gasper WJ, Sweet MP, Hoopes C, Leard LE, Kleinhenz ME, Hays SR, Golden JA, Patti MG| | View in PubMed
  63. Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma.
    Lee J, Sogutlu G, Leard L, Zarnegar R, Bailey J, Golden J, Hays S, Kebebew E, Duh QY, Clark O| | View in PubMed
  64. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation.
    Sweet MP, Patti MG, Leard LE, Golden JA, Hays SR, Hoopes C, Theodore PR| | View in PubMed
  65. Prevalence of delayed gastric emptying and gastroesophageal reflux in patients with end-stage lung disease.
    Sweet MP, Hoopes C, Golden J, Hays S, Leard L, Patti M| | View in PubMed
  66. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation.
    Sweet MP, Herbella FA, Leard L, Hoopes C, Golden J, Hays S, Patti MG| | View in PubMed
  67. Mesothelial cell proliferation and apoptosis.
    Leard LE, Broaddus VC| | View in PubMed